A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapy Article

International Collaboration

cited authors

  • Gubens, Matthew A.; Chuang, Jody C.; Akerley, Wallace; Langer, Corey J.; Clement-Duchene, Christelle; San Pedro-Salcedo, Melanie; Colevas, A. Dimitrios; Dragnev, Konstantin; Socinski, Mark A.; Wakelee, Heather A.

Publication Date

  • January 1, 2018

webpage

published in

category

keywords

  • Brain metastases
  • bevacizumab
  • non-small cell lung cancer (NSCLC)
  • pemetrexed

start page

  • 219

end page

  • 227

volume

  • 10

issue

  • 1